|
NIPD Genetics Limited, a private start-up company in Cyprus that has been developing a Non-Invasive Prenatal Diagnostic (NIPD) test for the detection of Down syndrome (trisomy 21), announced the findings of their most recent validation study in the journal, Prenatal Diagnosis. This study described the company’s...
|